Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Allosteric Bioscience is a preclinical-stage biotech company leveraging quantum computing and artificial intelligence to identify novel drug targets and modulators for aging, longevity, and age-related diseases. The company has entered into research collaborations with Johns Hopkins University for fundamental work on aging mechanisms, including progeria, and has licensed technology for the treatment/prevention of sarcopenia. No clinical results have been reported as of May 2025[1][4][5].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Allosteric Bioscience.